
Daniel Pollyea, MD, MS, is a hematologist-oncologist and physician-scientist. He is Division Chief of Hematology at the University of Colorado School of Medicine, Clinical Director of Leukemia Services, and the Robert H. Allen, MD Chair in Hematology Research. Clinically, he focuses on hematologic oncology, comprehensive care for blood cancers, and early-phase clinical trials. His research centers on cancer stem cell biology, translational development of novel therapeutics, and clinical trial design to accelerate curative strategies. He earned his medical degree from the University of Chicago Pritzker School of Medicine, completed internal medicine residency at the University of Chicago Hospital and served as Chief Medical Resident at Cook County Hospital, and finished hematology/oncology fellowship at Stanford University, where he also completed a master’s in epidemiology. Dr. Pollyea has been named a Scholar in Clinical Research by the Leukemia & Lymphoma Society, and recognized as the University of Colorado Department of Medicine Outstanding Early Career Scholar. He chairs the NCCN Acute Myeloid Leukemia Panel.
Division Chief, Hematology
Medical School
2003
Residency
Fellowship